Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31542580 | 1.00 | KDM4E (0.53) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL18380643 | 0.87 | KDM4E (0.61) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL29616919 | 0.87 | KDM4E (0.61) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL1535944 | 0.85 | KDM4E (0.53) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL14351749 | 0.84 | KDM4E (0.59) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL22051496 | 0.84 | KDM4E (0.51) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL4159068 | 0.81 | KDM4E (0.54) | KDM4EHTTATMALDH1A1LMNA | |
| SCHEMBL8855987 | 0.80 | KDM4E (0.58) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL4408132 | 0.80 | KDM4E (0.50) | KDM4EHTTATMALDH1A1HPGD | |
| SCHEMBL31048531 | 0.79 | KDM4E (0.53) | KDM4EHTTATMALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3106874-A | — | — | None | — | — | JP | disclosed |
| US-20230287217-A1 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | OREGON HEALTH & SCIENCE UNIVERSITY | 2023-09-14 | — | — | US | disclosed |
| US-20230287217-A1 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | OREGON HEALTH & SCIENCE UNIVERSITY | 2023-09-14 | — | — | US | disclosed |
| US-20230287217-A1 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | OREGON HEALTH & SCIENCE UNIVERSITY | 2023-09-14 | — | — | US | disclosed |
| EP-4225122-A1 | ZWITTERIONIC CELL-PERMEANT AND WATER-SOLUBLE RHODAMINE DYES FOR QUANTITATIVE IMAGING APPLICATIONS | Oregon Health & Science University (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-111171062-A | Method for synthesizing 2-carboxyl sodium phenylboronate | 大连双硼医药化工有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-10266503-B1 | Sulfoxide ligand metal catalyzed oxidation of olefins | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-04-23 | — | — | US | disclosed |
| US-6828159-B1 | Carbopyronine fluorescent dyes | Drexhage, Karl-Heinz (DE) | 2004-12-07 | — | — | US | disclosed |
| EP-1173519-B1 | NOVEL CARBOPYRONINE FLUORESCENCE DYES | DREXHAGE KARL-HEINZ (DE) | 2003-08-20 | — | — | EP | disclosed |
| EP-1173519-A1 | NOVEL CARBOPYRONINE FLUORESCENCE DYES | DREXHAGE, Karl-Heinz (DE) | 2002-01-23 | — | — | EP | disclosed |
| US-4301292-A | 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol | HOECHST-ROUSSEL PHARMACEUTICALS, INCORPORATED (US) | 1981-11-17 | — | — | US | disclosed |
| US-4292243-A | 3\"-Phenyldispiro[1,3-dioxolane-2,4'-cyclohexane-1',1\"-(3\"H)-isobenzofuran] | HOECHST ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-09-29 | — | — | US | disclosed |
| US-4292245-A | 3'-Phenylspiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-one | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-09-29 | — | — | US | disclosed |
| US-4290958-A | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-09-22 | — | — | US | disclosed |
| US-4288623-A | 1-Aryl-4-amino-cyclohexan-1-ols | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1981-09-08 | — | — | US | disclosed |
| EP-0027522-A1 | Spiro(cyclohexane-1,1'(3'H)-isobenzofuran)s, processes and intermediates for their preparation and pharmaceutical compositions containing them | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-04-29 | — | — | EP | disclosed |
| US-3985889-A | 1,3-DIHYDROSPIRO(ISOBENZOFURAN); ANALGETIC AGENTS | AMERICAN HOECHST CORPORATION (US) | 1976-10-12 | — | — | US | disclosed |
| US-3962259-A | TRANQUILIZERS, ANALGETIC AGENTS | AMERICAN HOECHST CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
| US-3959475-A | ANTIDEPRESSANT, TRANQUILIZER, ANALGESIC | AMERICAN HOECHST CORPORATION (US) | 1976-05-25 | — | — | US | disclosed |
| US-3957828-A | 3-Aminoalkyl-1,3-dihydro-3-phenylspiro[isobenzofurans] | AMERICAN HOECHST CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287217-A1 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | SLC1A5, SLCO1B1, SLCO2B1 | KDM4E 1806/4885HTT 2492/4885ATM 4650/4885 |
| US-10266503-B1 | Sulfoxide ligand metal catalyzed oxidation of olefins | YAP1, ICOSLG, SPIN3 | KDM4E 1925/4885HTT 3409/4885ATM 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.